Skip to Content

Dexchlorpheniramine / methscopolamine / pseudoephedrine Pregnancy and Breastfeeding Warnings

Dexchlorpheniramine / methscopolamine / pseudoephedrine is also known as: D-Hist D, DuraHist D, Histatab D

Dexchlorpheniramine / methscopolamine / pseudoephedrine Pregnancy Warnings

Dexchlorpheniramine/methscopolamine/pseudoephedrine has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. Dexchlorpheniramine/methscopolamine/pseudoephedrine is only recommended for use during pregnancy when benefit outweighs risk.

See references

Dexchlorpheniramine / methscopolamine / pseudoephedrine Breastfeeding Warnings

There are no data on the excretion of dexchlorpheniramine/methscopolamine/pseudoephedrine into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

See references

References for pregnancy information

  1. "Product Information. Durahist D (dexchlorpheniramine/methscopolamine/PSE)." ProEthic Laboratories LLC, Montgomery, AL.

References for breastfeeding information

  1. "Product Information. Durahist D (dexchlorpheniramine/methscopolamine/PSE)." ProEthic Laboratories LLC, Montgomery, AL.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide